Platinum versus non-platinum chemotherapy regimens for small cell lung cancer

Measuring inconsistency in meta-analyses

2003 • 53,662 citations

Reporting results of cancer treatment

1981 • 7,916 citations

Chapter 8: Assessing risk of bias in included studies

2008 • 3,591 citations

Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

1965 • 2,890 citations

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

Lung Cancer: Epidemiology, Etiology, and Prevention

2011 • 2,202 citations

Globocan 2000 : cancer incidence, mortality and prevalence worldwide

2001 • 1,504 citations

Published by John Wiley & Sons Ltd

2015 • 1,113 citations

Epidemiology of Lung Cancer

2010 • 1,094 citations

Epidemiology of Lung Cancer*

2003 • 733 citations

Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.

1978 • 705 citations

Chapter 12: Interpreting results and drawing conclusions

2011 • 658 citations

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

2006 • 654 citations

WHO handbook for reporting results of cancer treatment

1980 • 588 citations

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

1992 • 532 citations

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up

2002 • 487 citations

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1991 • 444 citations

Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?

2002 • 384 citations

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592

2002 • 373 citations

Oxford textbook of oncology

1996 • 311 citations

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

2000 • 282 citations

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

1995 • 267 citations

Staging and prognostic factors in small cell lung cancer: a consensus report

1989 • 256 citations

Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer

1987 • 227 citations

Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria

2003 • 222 citations

Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy

1997 • 208 citations

A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

1989 • 187 citations

Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732

2005 • 185 citations

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer

2004 • 167 citations

Asbestos, Lung Cancers, and Mesotheliomas

2010 • 166 citations

Longevity in small cell lung cancer

1990 • 158 citations

Oat cell carcinoma of the lung:A review of 138 cases

1969 • 150 citations

Chemotherapy advances in small-cell lung cancer.

2013 • 144 citations

Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment for Chemotherapy-Naive Patients With Extensive-Disease Small-Cell Lung Cancer

2006 • 140 citations

The EQ-5D Health-Related Quality of Life Questionnaire

2009 • 116 citations

Occupational exposure to carcinogens and risk of lung cancer: results from The Netherlands cohort study.

1997 • 88 citations

Chemotherapy Alonevs.Chemotherapy Plus High Dose Multiple Antioxidants in Patients with Advanced Non Small Cell Lung Cancer

2005 • 87 citations

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.

1987 • 87 citations

Platinum versus non-platinum chemotherapy regimens for small cell lung cancer

2015 • 82 citations

Limited-Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms

2010 • 81 citations

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.

1993 • 80 citations

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.

1990 • 68 citations

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized german multicenter trial

1987 • 66 citations

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

2003 • 65 citations

Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells

2016 • 63 citations

Oxford Textbook of Oncology

1996 • 61 citations

Quality-of-Life Considerations in Patients with Advanced Lung Cancer: Effect of Topotecan on Symptom Palliation and Quality of Life

2004 • 59 citations

Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma

2001 • 52 citations

Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer

2004 • 50 citations

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

2008 • 46 citations

A Phase III Trial Evaluating the Combination of Cisplatin, Etoposide, and Radiation Therapy With or Without Tamoxifen in Patients With Limited-Stage Small Cell Lung Cancer

2005 • 40 citations

Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.

1986 • 39 citations

Prospective Randomized Phase III Trial of Etoposide/Cisplatin Versus High-Dose Epirubicin/Cisplatin in Small-Cell Lung Cancer

2004 • 36 citations

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: An EORTC phase iii trial

1996 • 34 citations

The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma

1999 • 34 citations

A Randomized Phase III Study of Single-Agent Amrubicin Vs. Carboplatin/Etoposide in Elderly Patients With Extensive-Disease Small-Cell Lung Cancer

2013 • 30 citations

Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study.

1991 • 29 citations

A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer

2005 • 28 citations

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer

1990 • 28 citations

Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)

2002 • 27 citations

Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin

2016 • 27 citations

Enhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non–small-cell Lung Cancer

2016 • 26 citations

Split-Course Versus Continuous Thoracic Radiation Therapy for Limited-Stage Small-Cell Lung Cancer: Final Report of a Randomized Phase III Trial

2005 • 25 citations

Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer

2007 • 24 citations

Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC)

2005 • 21 citations

Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients

2016 • 19 citations

Standard combination versus alternating chemotherapy in small cell lung cancer

1999 • 18 citations

Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: A prospective randomized phase III trial

1995 • 16 citations

Randomized Phase III Trial of Cisplatin/Irinotecan Versus Cisplatin/Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer

2006 • 15 citations

Alternating Non-Cross Resistant Chemotherapy for Small Cell Lung Cancer

1986 • 13 citations

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first‐line treatment in patients with poor‐prognosis small cell lung carcinoma

2005 • 12 citations

Paclitaxel/Carboplatin/Etoposide Versus Paclitaxel/Topotecan for Extensive-Stage Small Cell Lung Cancer: A Minnie Pearl Cancer Research Network Randomized, Prospective Phase II Trial

2005 • 12 citations

Randomized Phase II Trial of High-Dose 4’-Epi-Doxorubicin + Cyclophosphamide versus High-Dose 4’-Epi-Doxorubicin + Cisplatin in Previously Untreated Patients with Extensive Small Cell Lung Cancer

1992 • 11 citations

Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).

1982 • 11 citations

Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II study

1992 • 11 citations

A meta-analysis of the role of etoposide (VP16) and cisplatin (CDDP) in small cell lung cancer (SCLC) with a methodology assessment

1999 • 11 citations

Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study

1994 • 10 citations

[Modalities of radiotherapy in small cell lung cancer: thoracic radiotherapy and prophylactic cerebral irradiation].

2004 • 10 citations

An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancer.

1981 • 8 citations

CVM versus ACE in the Treatment of Small Cell Lung Cancer

1993 • 6 citations

Does the substitution of cisplatin in a standard four drug regimen improve survival in small cell carcinoma of the lung? A comparison of two chemotherapy regimens.

1991 • 6 citations

Cisplatin-VP16 Alternating with Cyclophosphamide-Epirubicin versus Cyclophosphamide-Epirubicin-Vincristine in Small Cell Lung Cancer

1993 • 5 citations